Literature DB >> 12027406

Mechanism of inhibition of endothelin-1-stimulated proteoglycan and collagen synthesis in rat articular chondrocytes.

A-M Khatib1, G Siegfried, H Messai, F Moldovan, D R Mitrovic.   

Abstract

The aim of this study was to determine the effects of endothelin-1 (ET-1) on proteoglycan (PG) and collagen synthesis by rat articular chondrocytes (RAC). PG and collagen synthesis was measured by [(35)S]-sulphate and [(3)H]-glycine incorporation, respectively into monolayers of confluent RAC exposed to ET-1 (10(-11) M-10(-7) M). ET-1 stimulated PG and collagen synthesis in these cells in a concentration-dependent manner during the first 24 h of incubation. Prolonged contact of the cells with ET-1 resulted in a gradual decrease, and finally, inhibition of ET-1 effects. This inhibition is mediated by nitric oxide (NO) released in response to ET-1 since: (1) nitric oxide synthase inhibitor, nitro-L-arginine-methyl ester (L-NAME), enhanced both basal and ET-1-induced [(35)S]-sulphate and [(3)H]-glycine incorporations; (2) sodium nitroprusside (SNP), which spontaneously releases NO, inhibited both basal and ET-1-induced incorporations, and was also able to suppress the effects of L-NAME; (3) NO levels in the culture media were also correlated with the inhibition of [(35)S]-sulphate and [(3)H]-glycine incorporation; and (4) SNP also inhibited aggrecan and collagen II transcriptions, probably via cGMP. This effect was mimicked with 8-bromo-cGMP. Interestingly, the LY83583, which blocks the NO-dependent production and release of cGMP, inhibited PG-collagen synthesis but had no effect on their mRNA expressions. Thus, normal levels of cGMP appeared to be necessary for PG-collagen synthesis, whereas decreased levels are detrimental. In conclusion, NO, produced by rat AC in response to ET-1, counteracts the stimulation and finally induces inhibition of PG-collagen synthesis by ET-1 in these cells but NO-induced cGMP is only partially responsible for this inhibition. Copyright 2002 Elsevier Science Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027406     DOI: 10.1006/cyto.2001.1001

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  5 in total

Review 1.  Nitric oxide synthases and osteoarthritis.

Authors:  Jose U Scher; Michael H Pillinger; Steven B Abramson
Journal:  Curr Rheumatol Rep       Date:  2007-04       Impact factor: 4.592

2.  Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis.

Authors:  Gabriel N Kaufman; Charlotte Zaouter; Barthélémy Valteau; Pierre Sirois; Florina Moldovan
Journal:  Arthritis Res Ther       Date:  2011-05-16       Impact factor: 5.156

3.  Functionalized Nanogels with Endothelin-1 and Bradykinin Receptor Antagonist Peptides Decrease Inflammatory and Cartilage Degradation Markers of Osteoarthritis in a Horse Organoid Model of Cartilage.

Authors:  Aurélie Cullier; Frédéric Cassé; Seng Manivong; Romain Contentin; Florence Legendre; Aracéli Garcia Ac; Pierre Sirois; Gaëlle Roullin; Xavier Banquy; Florina Moldovan; Lélia Bertoni; Fabrice Audigié; Philippe Galéra; Magali Demoor
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

4.  Endothelin-1 in osteoarthritic chondrocytes triggers nitric oxide production and upregulates collagenase production.

Authors:  Christina Alexandra Manacu; Johanne Martel-Pelletier; Marjolaine Roy-Beaudry; Jean-Pierre Pelletier; Julio C Fernandes; Fazool S Shipkolye; Dragoslav R Mitrovic; Florina Moldovan
Journal:  Arthritis Res Ther       Date:  2005-01-17       Impact factor: 5.156

5.  Curcumin reduces prostaglandin E2, matrix metalloproteinase-3 and proteoglycan release in the secretome of interleukin 1β-treated articular cartilage.

Authors:  Abigail L Clutterbuck; David Allaway; Pat Harris; Ali Mobasheri
Journal:  F1000Res       Date:  2013-07-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.